Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2005 7
2006 1
2007 4
2008 3
2009 4
2010 11
2011 5
2012 3
2013 2
2014 2
2015 4
2016 3
2017 3
2018 1
2019 3
2020 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Transgenic modifications of the rat genome.
Tesson L, Cozzi J, Ménoret S, Rémy S, Usal C, Fraichard A, Anegon I. Tesson L, et al. Among authors: usal c. Transgenic Res. 2005 Oct;14(5):531-46. doi: 10.1007/s11248-005-5077-z. Transgenic Res. 2005. PMID: 16245144 Review.
IL-34 deficiency impairs FOXP3+ Treg function in a model of autoimmune colitis and decreases immune tolerance homeostasis.
Freuchet A, Salama A, Bézie S, Tesson L, Rémy S, Humeau R, Règue H, Sérazin C, Flippe L, Peterson P, Vimond N, Usal C, Ménoret S, Heslan JM, Duteille F, Blanchard F, Giral M, Colonna M, Anegon I, Guillonneau C. Freuchet A, et al. Among authors: usal c. Clin Transl Med. 2022 Aug;12(8):e988. doi: 10.1002/ctm2.988. Clin Transl Med. 2022. PMID: 36030499 Free PMC article.
Cross-Reactive Donor-Specific CD8+ Tregs Efficiently Prevent Transplant Rejection.
Picarda E, Bézie S, Usero L, Ossart J, Besnard M, Halim H, Echasserieau K, Usal C, Rossjohn J, Bernardeau K, Gras S, Guillonneau C. Picarda E, et al. Among authors: usal c. Cell Rep. 2019 Dec 24;29(13):4245-4255.e6. doi: 10.1016/j.celrep.2019.11.106. Cell Rep. 2019. PMID: 31875536 Free article.
Genome Editing in Rats Using TALE Nucleases.
Tesson L, Remy S, Ménoret S, Usal C, Thinard R, Savignard C, De Cian A, Giovannangeli C, Concordet JP, Anegon I. Tesson L, et al. Among authors: usal c. Methods Mol Biol. 2016;1338:245-59. doi: 10.1007/978-1-4939-2932-0_18. Methods Mol Biol. 2016. PMID: 26443226
Anti-CD45RC antibody immunotherapy prevents and treats experimental autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.
Besnard M, Sérazin C, Ossart J, Moreau A, Vimond N, Flippe L, Sein H, Smith GA, Pittaluga S, Ferré EM, Usal C, Anegon I, Ranki A, Lionakis MS, Peterson P, Guillonneau C. Besnard M, et al. Among authors: usal c. J Clin Invest. 2022 Apr 1;132(7):e156507. doi: 10.1172/JCI156507. J Clin Invest. 2022. PMID: 35167497 Free PMC article.
In Vivo Analysis of Human Immune Responses in Immunodeficient Rats.
Ménoret S, Ouisse LH, Tesson L, Remy S, Usal C, Guiffes A, Chenouard V, Royer PJ, Evanno G, Vanhove B, Piaggio E, Anegon I. Ménoret S, et al. Among authors: usal c. Transplantation. 2020 Apr;104(4):715-723. doi: 10.1097/TP.0000000000003047. Transplantation. 2020. PMID: 31764762 Free PMC article.
Advances in transgenic animal models and techniques.
Ménoret S, Tesson L, Remy S, Usal C, Ouisse LH, Brusselle L, Chenouard V, Anegon I. Ménoret S, et al. Among authors: usal c. Transgenic Res. 2017 Oct;26(5):703-708. doi: 10.1007/s11248-017-0038-x. Epub 2017 Aug 5. Transgenic Res. 2017. PMID: 28780744
Characterization of immunoglobulin heavy chain knockout rats.
Ménoret S, Iscache AL, Tesson L, Rémy S, Usal C, Osborn MJ, Cost GJ, Brüggemann M, Buelow R, Anegon I. Ménoret S, et al. Among authors: usal c. Eur J Immunol. 2010 Oct;40(10):2932-41. doi: 10.1002/eji.201040939. Eur J Immunol. 2010. PMID: 21038471 Free article.
59 results